Take Back Control

The short picture on Take Back Control (Indianapolis, IN): The facility's programming is outpatient (IOP, Dual Dx), not residential. The longer picture — clinical framework, payer mix, outcomes — takes a few specific questions to surface.

Care levels at Take Back Control

What Take Back Control offers: Take Back Control is an outpatient-focused program (IOP, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. What matters is whether that matches the specific clinical picture, which only a proper assessment can tell. Most mismatches happen when the assessment is skipped or done inside the facility with a commercial interest in admission.

Insurance and payment

Take Back Control accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. The uncomfortable truth about insurance at most treatment centers is that admissions staff and the utilization-review team sometimes have different understandings of what was promised. Written VOB forces those understandings into alignment.

Specialty programming

The facility's documented specialty programming includes: Adolescents, Young adults, Adult women. "Specialty track" is a marketing category often; it becomes a clinical category when specific clinicians deliver specific programming for a documented number of hours per week. Ask for those specifics.

Before you call

Questions that matter before admitting to Take Back Control: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Take Back Control offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.